Mots-clés

Co-auteurs

Nom des revues

Export Publications

Exporter les publications affichées :
Nombre de documents

107

Lionel Perrier


Article dans une revue52 documents

  • Lionel Perrier, Pauline Rascle, Magali Morelle, Maud Toulmonde, Dominique Ranchere Vince, et al.. The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group. PLoS ONE, Public Library of Science, 2018, 13 (4), 〈10.1371/journal.pone.0193330〉. 〈halshs-01784301〉
  • Patricia Marino, Rajae Touzani, Lionel Perrier, Etienne Rouleau, Dede Sika Kossi, et al.. Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study. European Journal of Human Genetics, Nature Publishing Group, 2018, 26, pp. 314-323. 〈10.1038/s41431-017-0081-3〉. 〈halshs-01703194〉
  • Olivia Pérol, Barbara Charbotel, Lionel Perrier, Sandrine Bonnand, Elodie Belladame, et al.. Systematic Screening for Occupational Exposures in Lung Cancer Patients: A Prospective French Cohort. International Journal of Environmental Research and Public Health, MDPI, 2018, 15 (1), pp.65. 〈10.3390/ijerph15010065〉. 〈halshs-01704517〉
  • Marius Huguet, Lionel Perrier, Olivia Bally, David Benayoun, Pierre De Saint Hilaire, et al.. Being Treated In Higher Volume Hospitals Leads To Longer Progression-Free Survival For Epithelial Ovarian Carcinoma Patients in the Rhone-Alpes region of France. BMC Health Services Research, BioMed Central, 2018, 18 (3), 11 p. 〈10.1186/s12913-017-2802-2〉. 〈halshs-01670155〉
  • Olfa Rejeb, Claire Pilet, Sabri Hamana, Xie Xiaolan, Thierry Durand, et al.. Performance and cost evaluation of health information systems using micro-costing and discrete-event simulation. Health Care Management Science, Springer Verlag, In press, A paraître. 〈10.1007/s10729-017-9402-x〉. 〈halshs-01526704〉
  • Jean-Emmanuel Bibault, Magali Morelle, Marius Huguet, Lionel Perrier, Philippe Giraud. In reply to Tallet et al.. International Journal of Radiation Oncology - Biology - Physics, Elsevier, 2018, 100 (2), pp. 529-530. 〈halshs-01651499〉
  • Jean-Emmanuel Bibault, Magali Morelle, Marius Huguet, Lionel Perrier, Philippe Giraud. In reply to Jean-François Daisne, Sandra Nuyts, Fréderic Duprez and Benoît Bihin. International Journal of Radiation Oncology - Biology - Physics, Elsevier, 2018, 100 (3), pp. 808-809. 〈halshs-01651501〉
  • Magali Morelle, Morgane Plantier, Benoît Dervaux, Arnaud Pagès, Fanette Deniès, et al.. Méthodes d’analyse et de traitement des données de coût : approches par « micro-costing » et « gross-costing ». Epidemiology and Public Health / Revue d'Epidémiologie et de Santé Publique, Elsevier Masson, 2018, 66, pp.S101 - S118. 〈10.1016/j.respe.2018.02.003〉. 〈halshs-01784310〉
  • Mélanie Varin, Barbara Charbotel, Olivia Pérol, Lionel Perrier, Amélie Massardier-Pilonchéry, et al.. Évaluation d’un auto-questionnaire de repérage des expositions professionnelles chez les patients atteints de cancer bronchopulmonaire. Bulletin du Cancer, John Libbey Eurotext, 2017, 104 (6), pp. 559-564. 〈10.1016/j.bulcan.2017.03.014〉. 〈halshs-01526744〉
  • Mathilde Penel-Page, Perrine Marec-Berard, Magali Morelle, Amandine Bertrand, Christèle Riberon, et al.. Management of Febrile Neutropenias in Adolescents and Young Adults: A Cost-Minimization Analysis Between Adult Versus Pediatric Units. Journal of Adolescent and Young Adult Oncology, 2017, 6 (4), pp. 542-550. 〈10.1089/jayao.2017.0035〉. 〈halshs-01618890〉
  • Nathalie Havet, Alexis Penot, Magali Morelle, Lionel Perrier, Barbara Charbotel, et al.. Trends in occupational disparities for exposure to carcinogenic, mutagenic and reprotoxic chemicals in France 2003–10 . European Journal of Public Health, Oxford University Press (OUP): Policy B - Oxford Open Option D, 2017, 27 (3), pp. 425-432. 〈halshs-01524444〉
  • Morgane Plantier, Nathalie Havet, Thierry Durand, Nicolas Caquot, Camille Amaz, et al.. Does adoption of electronic health records improve organizational performances of hospital surgical units? Results from the French e-SI (PREPS-SIPS) study. International Journal of Medical Informatics, Elsevier, 2017, 98, pp. 47-55. 〈10.1016/j.ijmedinf.2016.12.002〉. 〈halshs-01421101〉
  • Morgane Plantier, Nathalie Havet, Thierry Durand, Nicolas Caquot, Camille Amaz, et al.. Does adoption of electronic health records improve the quality of care management in France? Results from the French e-SI (PREPS-SIPS) study. International Journal of Medical Informatics, Elsevier, 2017, 102, pp. 156-165. 〈10.1016/j.ijmedinf.2017.04.002〉. 〈halshs-01619178〉
  • Lionel Perrier, Magali Morelle, Marius Huguet, Sophie Dussart, Philippe Giraud. In Reply to Escande et al. International Journal of Radiation Oncology - Biology - Physics, Elsevier, 2017, 97 (1), pp. 205-208. 〈halshs-01421123〉
  • Jean-Emmanuel Bibault, Sophie Dussart, Pascal Pommier, Magali Morelle, Marius Huguet, et al.. Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score–Weighted Analysis. International Journal of Radiation Oncology - Biology - Physics, Elsevier, 2017, 99 (4), pp. 929-937. 〈10.1016/j.ijrobp.2017.06.2456〉. 〈halshs-01618896〉
  • Séverine Guillemaut, Magali Morelle, Abdel Achache, Anne-Gaëlle Le Coroller Soriano, David Pérol, et al.. ISO 9001 certification of innovation and clinical research departments: Extending the scope of health assessment. Epidemiology and Public Health / Revue d'Epidémiologie et de Santé Publique, Elsevier Masson, 2017, 65 (2), pp. 159-167. 〈halshs-01426436〉
  • Nathalie Havet, Alexis Penot, Magali Morelle, Lionel Perrier, Barbara Charbotel, et al.. Varied exposure to carcinogenic, mutagenic, and reprotoxic (CMR) chemicals in occupational settings in France. International Archives of Occupational and Environmental Health, Springer Verlag, 2017, 90 (2), pp. 227-241. 〈halshs-01446700〉
  • Antony Ceraulo, Antoine Ouziel, Emilie Lavergne, Lionel Perrier, Anne-Valérie Decouvelaere, et al.. Percutaneous guided biopsy for diagnosing suspected primary malignant bone tumors in pediatric patients: a safe, accurate, and cost-saving procedure. Pediatric Radiology, Springer Verlag, 2017, 47 (2), pp. 235-244. 〈10.1007/s00247-016-3735-3〉. 〈halshs-01421085〉
  • Noémie Defourny, Peter Dunscombe, Lionel Perrier, Cai Grau, Yolande Lievens. Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysis. Radiotherapy and Oncology, Elsevier, 2016, 121 (3), pp. 468-474. 〈halshs-01421113〉
  • Morgane Plantier, Nathalie Havet, Nicolas Caquot, Pierre Biron, Camille Amaz, et al.. Impact of Electronic Health Records on the Hospital Bed Occupancy Rates in Surgical Units in France: Results from the E-SI (PREPS-SIPS) Study. Athens Journal of Health, Health Sciences Research Division of ATINER, 2016, 3 (1), pp. 11-26. 〈halshs-01237499〉
  • Lionel Perrier, Magali Morelle, Sophie Dussart, Philippe Giraud. In Reply to Fodor and Di Muzio. International Journal of Radiation Oncology - Biology - Physics, Elsevier, 2016, 96 (5), pp. 1124-1126. 〈halshs-01421125〉
  • Lionel Perrier, Magali Morelle, Pascal Pommier, Pierre Boisselier, Bernard Coche-Dequeant, et al.. A cost analysis of complex radiotherapy for patients with head and neck cancer. International Journal of Radiation Oncology - Biology - Physics, Elsevier, 2016, 95 (2), pp. 654-662 〈10.1016/j.ijrobp.2016.02.013〉. 〈halshs-01300834〉
  • Anne-Isabelle Poullié, Magali Cognet, Aline Gauthier, Marine Clementz, Sylvain Druais, et al.. Cost-Effectiveness Of Treatments For Mild-To-Moderate Obstructive Sleep Apnea In France. International Journal of Technology Assessment in Health Care, Cambridge University Press (CUP), 2016, 32 (1), pp. 1-9. 〈10.1017/S0266462316000088〉. 〈halshs-01327109〉
  • Maria-Laura Silva, Lionel Perrier, John Paget, Anne Mosnier, Valérie Buthion, et al.. Influenza vaccination policy-making processes in France and The Netherlands: Framework and determinants. Health Policy, Elsevier, 2016, 120 (3), pp. 293-305. 〈halshs-01266374〉
  • J-E Bibault, Magali Morelle, Lionel Perrier, Pascal Pommier, Pierre Boisselier, et al.. Toxicity and efficacy of cetuximab associated with several modalitiesof IMRT for locally advanced head and neck cancer. Cancer Radiothérapie, Elsevier Masson, 2016, 20 (5), pp. 357-361. 〈halshs-01366224〉
  • Maria-Laura Silva, John Paget, Anne Mosnier, Valérie Buthion, Jean Marie Cohen, et al.. Development of Seasonal Influenza Vaccination Recommendations: Relevance and Influence of the Evidence on the Decision-Making Process in France and the Netherlands. Value in Health, Elsevier, 2016, 19 (5), pp. 670-679. 〈halshs-01366179〉
  • Morgane Plantier, Nathalie Havet, Nicolas Caquot, Pierre Biron, Camille Amaz, et al.. Impact of Electronic Health Records on the Hospital Bed Occupancy Rates in Surgical Units in France: Results from the E-SI (PREPS-SIPS) Study. ATINER’S Conference Paper Series, Athens Institute for Education and Research, 2015, 20 p. 〈halshs-01237556〉
  • Maria-Laura Silva, Lionel Perrier, Jean Marie Cohen, William Paget, Anne Mosnier, et al.. A literature review to identify factors that determine policies for influenza vaccination. Health Policy, Elsevier, 2015, 119 (6), pp. 697-708. 〈10.1016/j.healthpol.2015.04.006〉. 〈halshs-01156520〉
  • Alessandra Buja, Diego Martines, Salvatore Lobello, Lionel Perrier. A cost-consequence analysis of hepatitis B screening in an immigrant population. Annali dell'Istituto Superiore di Sanità, Istituto Superiore di Sanità, 2015, 51 (5), pp. 327-335. 〈halshs-01237025〉
  • Nathalie Havet, Alexis Penot, Magali Morelle, Lionel Perrier, Béatrice Fervers. Inégalités de l'exposition aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel en France. Environnement, Risques and Santé, John Libbey Eurotext, 2014, 13 (4), pp. 336-341. 〈halshs-01080555〉
  • Maria-Laura Silva, Lionel Perrier, Hans-Martin Späth, Nathalie Havet, Jean Marie Cohen, et al.. Economic burden of seasonal influenza B in France during winter 2010-2011. BMC Public Health, BioMed Central, 2014, 14 (1), art. 56, 10 p. 〈10.1186/1471-2458-14-56〉. 〈halshs-00954697〉
  • Lionel Perrier, Alessandra Buja, Giuseppe Mastrangelo, Patrick Sylvestre-Baron, Françoise Ducimetière, et al.. Transferability of health cost evaluation across locations in oncology: cluster and principal component analysis as an explorative tool. BMC Health Services Research, BioMed Central, 2014, 14 (1), p. 537. 〈halshs-01089763〉
  • David G. Cox, Stéphane Ragusa, Lionel Pourteau, Lionel Perrier, Suzette Delaloge. Cost-effectiveness of a Genetic Test for Breast Cancer Risk - Letter. Cancer Prevention Research, American Association for Cancer Research, 2014, 〈10.1158/1940-6207.CAPR-13-0429〉. 〈halshs-00957846〉
  • Lionel Perrier, Magali Morelle, Pascal Pommier, Jean-Léon Lagrange, Agnès Laplanche, et al.. Cost of prostate image-guided radiation therapy: results of a randomized trial.. Radiotherapy and Oncology, Elsevier, 2013, 106 (1), pp.50-8. 〈10.1016/j.radonc.2012.11.011〉. 〈hal-00880252〉
  • Lionel Perrier, Magali Morelle, Pascal Pommier. Cost of prostate image-guided radiation therapy: Results of a randomized trial. Radiotherapy and Oncology, Elsevier, 2013, 106 (1), pp. 50-58. 〈halshs-00799507〉
  • Marina Touillaud, Aude-Marie Foucaut, Sophie Berthouze, Eric Reynes, A. S. Kempf-Lépine, et al.. Design of a randomised controlled trial of adapted physical activity during adjuvant treatment for localised breast cancer: the PASAPAS feasibility study. BMJ Open, BMJ Publishing Group, 2013, 3, pp.e003855. 〈10.1136/bmjopen-2013-003855〉. 〈halshs-00940932〉
  • Magali Morelle, Lionel Perrier, Pascal Pommier, Frédéric Gomez, F. Millet-Lagarde, et al.. Curiethérapie : valorisation et aspects médico-économiques. Cancer Radiothérapie, Elsevier Masson, 2013, 17 (2), pp. 178-181. 〈halshs-00862738〉
  • Lionel Perrier, Anne Lefranc, Philippe Quittet, Philippe Moreau, Carole Siani, et al.. Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma. Applied Health Economics and Health Policy, Adis, 2013, 11 (2), pp. 129-138. 〈halshs-00752571〉
  • Catherine Sebban, Anne Lefranc, Lionel Perrier, Philippe Moreau, Daniel Espinouse, et al.. A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study). European Journal of Cancer, Elsevier, 2012, 48 (5), pp. 713-720. 〈halshs-00680996〉
  • Lionel Perrier, Alessandra Buja, Giuseppe Mastrangelo, Antonella Vecchiato, Paolo Sandonà, et al.. Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions.. BMC Health Services Research, BioMed Central, 2012, 12 (1), pp.82. 〈10.1186/1472-6963-12-82〉. 〈inserm-00711845〉
  • Magali Morelle, Lionel Perrier, Pascal Pommier, Renaud De Crevoisier, Agnès Laplanche, et al.. Evaluation économique prospective de la radiothérapie guidée par l'image des cancers de la prostate dans le cadre du programme national de Soutien aux Thérapeutiques Innovantes et Coûteuses. Cancer Radiothérapie, Elsevier Masson, 2012, 16 (5-6), pp. 444-451. 〈halshs-00752616〉
  • Nora Moumjid, Lionel Perrier, Maria-Laura Silva, Hans-Martin Späth. The use of economic evaluations in health decision-making at the macro level: a literature review. Journal de Gestion et d’Économie Médicales, Editions ESKA, 2012, 30 (4), pp. 231-251. 〈halshs-00752572〉
  • Nathalie Havet, Magali Morelle, Lionel Perrier, Bertrand Favier, Frédéric Gomez, et al.. Impact of chemotherapy prescriptions and costs on survival in advanced or metastatic NSCLC: a single-institution study using an instrumental variables approach. Journal d'Economie Médicale, 2010, 28 (8), pp. 295-310. 〈halshs-00667277〉
  • Lionel Perrier, Thierry Philip. Apports de l'évaluation économique et de l'analyse d'impact budgétaire pour la décision publique en santé : l'exemple du cancer du sein. Bulletin du Cancer, John Libbey Eurotext, 2010, 97 (3), pp. 397-402. 〈halshs-00565785〉
  • Christophe Bergeron, Pierre Biron, Jean-Yves Blay, Nicola Cautela, Dominic Cellier, et al.. Costs and compliance with clinical practice guidelines: A pilot study for initial sarcoma treatment. Journal d'Economie Médicale, 2009, 27 (6), pp. 307-327. 〈halshs-00954975〉
  • Lionel Perrier, Pascal Pommier, Marie-Odile Carrère, Patrick Sylvestre-Baron. Transférabilité des évaluations de coûts en santé : analyse des facteurs de variabilité. Revue Economique, Presses de Sciences Po, 2009, 60 (2), pp. 307-322. 〈halshs-00451617〉
  • Lionel Perrier, S.E. Combs, Thomas Auberger, Luciano Zucca, Ingemar Näslund, et al.. A Decision-making Tool for a Costly Innovative Technology: The Case of Carbon Ion Radiotherapy. Journal d'Economie Médicale, 2008, 25 (7-8), pp. 367-380. 〈halshs-00353062〉
  • Magali Morelle, Lionel Perrier, Hervé Ghesquières, Catherine Sebban, Irène Philip, et al.. The impact of CD34+ cell dose on the cost of HDT with PBSC transplantation in lymphomia. Journal dÉconomie Médicale, 2007, 25 (1), pp.3-15. 〈halshs-00159806〉
  • Lionel Perrier, Thierry Philip. Trajectoires optimales des patients évoluant vers la dépendance. Sante et Systemique, Editions Hermes, 2005, 8 (3 - 4), pp.73-86. 〈halshs-00157163〉
  • Pascal Pommier, Luciano Zucca, Ingemar Näslund, Thomas Auberger, Stephanie E. Combs, et al.. Light ion facility projects in Europe: methodological aspects for the calculation of the treatment cost per protocol. Radiotherapy and Oncology, Elsevier, 2004, 73 (Supplement 2), pp.183-185. 〈10.1016/S0167-8140(04)80045-8〉. 〈halshs-00156706〉
  • Lionel Perrier, Karima Nessah, Magali Morelle, Hervé Mignotte, Marie-Odile Carrère, et al.. Cost comparison of two surgical strategies in the treatment of breast cancer: Sentinel lymph node biopsy versus axillary lymph node dissection. International Journal of Technology Assessment in Health Care, Cambridge University Press (CUP), 2004, 20 (4), pp. 449-454. 〈halshs-00335472〉
  • Lionel Perrier, Catherine Sebban, Irène Philip, Baudouin Standaert, Magali Morelle, et al.. Vers une nécessaire harmonisation des évaluations de coûts en santé. L'exemple des intensifications thérapeutiques avec autogreffes de cellules souches du sang périphérique en France. Epidemiology and Public Health / Revue d'Epidémiologie et de Santé Publique, Elsevier Masson, 2002, 50 (4), pp. 393-403. 〈halshs-00335619〉

Communication dans un congrès46 documents

  • Sandrine Baffert, Julia Bonastre, Mercier Grégoire, Lionel Perrier. Guide méthodologique sur le calcul et l’analyse des coûts hospitaliers. Journée Echelle Nationale de Coût (ENC) de l’Agence technique de l’information sur l’hospitalisation (ATIH), Paris, 4 juillet 2017, Oct 2017, Paris, France. 2017. 〈halshs-01619444〉
  • Lionel Perrier. Analyse des corrélations entre informatisation et performance des établissements de santé . Séminaire sur le programme de recherche sur la performance du système de soins (PREPS), Agence Nationale d'Appui à la Performance des établissements de santé et médico-sociaux (ANAP), Paris, 4 mai 2017, May 2017, Paris, France. 2017. 〈halshs-01569065〉
  • Lionel Perrier, Noémie Defourny, Peter Dunscombe, Cai Grau, Yolande Lievens. Cost of radiotherapy: what is the quality of the evidence found? Critical quality appraisal of studies estimating cost of radiotherapy. European Society for Radiotherapy & Oncology (ESTRO) 36, Vienne (Autriche), 5-9 mai 2017, May 2017, Vienne, Austria. 2017. 〈halshs-01654668〉
  • Lionel Perrier. Does adoption of electronic heath record improve the quality of care management?. Biovision, Workshop Digital health and innovation for sustainable healthcare, Lyon, 4 avril 2017, Apr 2017, Lyon, France. 2017. 〈halshs-01661998〉
  • Lionel Perrier. Does adoption of electronic records improve organizational performances of hospital surgical units?. Biovision, Workshop Digital health and innovation for sustainable healthcare, Lyon, 4 avril 2017, Apr 2017, Lyon, France. 2017. 〈halshs-01661999〉
  • Lionel Perrier. Radiotherapy costs: the good, the bad and the ugly. European Society for Radiotherapy & Oncology (ESTRO) 36, Vienne (Autriche), 5-9 mai 2017, May 2017, Vienne, Austria. 2017. 〈halshs-01527903〉
  • Lionel Perrier. Les impacts médico-économiques de l'évolution du parcours de soins en cancérologie. 15ème journée annuelle du réseau ONCOCENTRE, Tours, 7 décembre 2017, Dec 2017, Tours, France. 〈halshs-01670547〉
  • Aude-Marie Foucaut, Marina Touillaud, A. S. Kempf-Lépine, Magali Morelle, Dominik Heinz, et al.. A cost-effectiveness analysis of a 6-month physical activity program versus usual dietary care during adjuvant chemotherapy in breast cancer: An economic evaluation of the PASAPAS trial. . 21th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Washington Hilton, Washington DC, 16-20 mai 2016, May 2016, Washington, United States. 3, 2016. 〈halshs-01421080〉
  • Lionel Perrier, Nathalie Havet, Irène Philip, Thierry Durand, Nicolas Caquot, et al.. Impact of health information systems on hospital bed occupancy rates in French hospitals: results from the e-SI (PREPS-SIPS) study. 21th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Washington Hilton, Washington DC, 16-20 mai 2016, May 2016, Washington, United States. 〈halshs-01421058〉
  • Maria-Laura Silva, Lionel Perrier, Hans-Martin Späth, John Paget, Valérie Buthion, et al.. General Practitioners Perceptions About Financial and Non-Financial Incentives to Improve Influenza Vaccination Coverage Rates In France. ISPOR 19th Annual European Congress, Vienne (Autriche), 29 octobre- 2 novembre 2016, Oct 2016, Vienne, Austria. 19 (7), pp.A422, 2016, Value in Health. 〈halshs-01439558〉
  • Lionel Perrier. Cost Analysis of Human Genome Sequencing in Cancer Diagnosis in France: Next Generation Sequencing. ISPOR 19th Annual European Congress, Vienne (Autriche), 29 octobre- 2 novembre 2016, Oct 2016, Vienne, Austria. 19 (7), pp.A693, 2016, Value in Health. 〈halshs-01439566〉
  • Claire Pilet, Vincent Augusto, Sabri Hamana, Thierry Durand, Saber Aloui, et al.. Is the Integrated Electronic Health Record Cost-Effective for a Cancer Consultation? Results from the E-SI (PREPS-SIPS) Study. ISPOR 19th Annual European Congress, Vienne (Autriche), 29 octobre- 2 novembre 2016, Oct 2016, Vienne, Austria. 19 (7), pp.A735, 2016, Value in Health. 〈halshs-01439407〉
  • Lionel Perrier, Pascale Guerre. Guide méthodologique sur le costing à l’Hôpital. 38èmes Journées des Economistes de la Santé Français (JESF), Lyon, 1er-2 décembre 2016, Dec 2016, Lyon, France. 2016. 〈halshs-01500548〉
  • Lionel Perrier, Morgane Plantier, Nathalie Havet, Thierry Durand, Nicolas Caquot, et al.. Système d'information et performance hospitalière. Journées nationales "Accompagnement Hôpital Numérique", Paris, 4 février 2016, Feb 2016, Paris, France. 2016. 〈halshs-01301932〉
  • Dede Sika Kossi, Rajae Touzani, Isabelle Borget, Zhaomin Zou, Dominique Vaur, et al.. Cost Analysis of Human Genome Sequencing in Cancer Diagnosis in France: Next Generation Sequencing. ISPOR 19th Annual European Congress, Vienne (Autriche), 29 octobre- 2 novembre 2016, Oct 2016, Vienne, Austria. 19 (7), pp.A693, 2016, Value in Health. 〈halshs-01446644〉
  • Carole Siani, Christian De Peretti, Julie A Vendrell, Balazs Gyorffy, Thomas Bachelot, et al.. A cost-effectiveness analysis of the ZIRA test in breast cancer. 21th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Hilton, Washington DC, USA, 21-25 mai 2016, May 2016, Washington, United States. 2016. 〈halshs-01366993〉
  • Lionel Perrier, Morgane Plantier, Nathalie Havet, Thierry Durand, Nicolas Caquot, et al.. Dossier Patient Informatisé : quel impact sur la performance des établissements de santé en France ?. Séminaire à l’Institut de Santé Publique, épidémiologie et développement ISPED, Université Victor Segalen, Bordeaux, 4 mai 2016, May 2016, Bordeaux, France. 2016. 〈halshs-01328996〉
  • Lionel Perrier, Morgane Plantier, Fadila Farsi, Patrick Vandenbergh, Hervé Spacagna, et al.. Why should we focus on a structured model of secure digital exchanges to incorporate new documents in electronic patient records?. ISPOR 19th Annual European Congress, Vienne (Autriche), 29 octobre- 2 novembre 2016, Oct 2016, Vienne, Austria. 19 (7), pp.A626, 2016, Value in Health. 〈halshs-01439348〉
  • Lionel Perrier. Relationship between the development of electronic health records and hospital accreditation decisions in France: results from the E-SI (Preps-Sips). 20th Annual International Meeting de l'International Society for Pharmacoeconomics Outcomes Research (ISPOR), Philadelphie, Etats-Unis, 16-20 mai 2015, May 2015, Philadelphie, United States. 2015. 〈halshs-01178650〉
  • Lionel Perrier, Nathalie Havet, Irène Philip, Thierry Durand, Nicolas Caquot, et al.. Health Information System Adoption And Hospital Accreditation Decisions In France: Results From The E-SI (PREPS-SIPS) Study. 11th World Congress in Health Economics, Milan, Italie, 12-15 juillet 2015, Jul 2015, Milan, Italy. 2015. 〈halshs-01193143〉
  • Alexis Penot, Magali Morelle, Béatrice Fervers, Lionel Perrier. Inégalités de l’exposition aux produits chimiques cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel : les enseignements de l’enquête SUMER. Risques au travail : autour de SUMER 2010, 1er octobre 2014, Paris, France, Oct 2014, Paris, France. 〈halshs-01076915〉
  • Nathalie Havet, Magali Morelle, Alexis Penot, Béatrice Fervers, Lionel Perrier. Les fortes expositions aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) sont-elles l'apanage des emplois précaires et peu qualifiés ?. Journée d'Economie et de Gestion Médicale, Paris, 28 janvier 2014, Jan 2014, Paris, France. 〈halshs-00954964〉
  • Lionel Perrier. Cost of physical activity intervention during adjuvant chemotherapy in breast cancer: results of the randomized trial PASAPAS. 8èmes journées scientifiques du Cancéropôle Lyon Auvergne Rhône-Alpes, Lyon, 21 et 22 mars 2013, Mar 2013, Lyon, France. 〈halshs-00829582〉
  • Maria-Laura Silva, Lionel Perrier, Hans-Martin Späth, Nathalie Havet, Jean Marie Cohen, et al.. Economic burden of seasonal influenza B in France during winter 2010-2011. Options for the Control of Influenza, Cape Town, 7 septembre 2013, Sep 2013, Le Cap, South Africa. 〈halshs-00954710〉
  • Nathalie Havet, Magali Morelle, Alexis Penot, Béatrice Fervers, Lionel Perrier. Inégalités de l'exposition aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel : SUMER 2010. 4ème Congrès Cancer et Environnement de la Société Française Santé et Environnement, Lyon, 28-29 novembre 2013, Nov 2013, Lyon, France. 〈halshs-00954966〉
  • Lionel Perrier. A cost-analysis of stereotactic radiotherapy in lung cancer. 16th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research, Dublin, Irlande, 4 novembre 2013, Nov 2013, Dublin, Irlande. 〈halshs-00952329〉
  • Lionel Perrier. Comprendre les analyses médico-économiques : intervention didactique à l'intention des cliniciens. 9èmes Journées annuelles du Groupe Sarcome Français, Strasbourg, 28 juin 2013, Jun 2013, Strasbourg, France. 〈halshs-00940941〉
  • Maria-Laura Silva, Lionel Perrier, Hans-Martin Späth, Nathalie Havet, Jean Marie Cohen, et al.. Economic burden of seasonal influenza B in France during winter 2010-2011. ISPOR 15th Annual European Congress, Berlin, 7 novembre 2012, Nov 2012, Berlin, Germany. 〈halshs-00954709〉
  • Lionel Perrier. Cost-effectiveness analysis: an interdisciplinary research and methodological perspective. University degli Studi di Padova, Italy, July 19th, 2012, Jul 2012, Padova, Italy. 〈halshs-00752916〉
  • Lionel Perrier, Dominique Ranchère-Vince, P. Terrier, A. Neuville, Anne-Valérie Decouvelaere, et al.. Discordant diagnoses in sarcoma, GIST and desmoide tumour in France: results from the network RREPS. ISPOR, 15th Annual European Congress 3-7 November 2012, Berlin, Germany, Nov 2012, Berlin, Germany. 15 (7), page A285, 2012. 〈halshs-00752854〉
  • Pascal Pommier, Magali Morelle, Lionel Perrier, Renaud De Crevoisier, A. Laplanche, et al.. Évaluation économique prospective de la radiothérapie guidée par l'image des cancers de la prostate dans le cadre du programme national de soutien aux thérapeutiques innovantes et coûteuses. [Prospective economic evaluation of image-guided radiation therapy for prostate cancer in the framework of the national programme for innovative and costly therapies assessment.]. 23e Congrès national de la Société française de radiothérapie oncologique (SFRO), Sep 2012, Paris, France. 16 (5-6), pp.444-451, 2012, 〈10.1016/j.canrad.2012.07.178〉. 〈hal-00905545〉
  • Lionel Perrier, Magali Morelle, Pascal Pommier, Jean-Léon Lagrange, Agnès Laplanche, et al.. A cost-analysis of image-guided radiation therapy (IGRT) in prostate cancer: results from a phase III clinical trial. ISPOR, 15th Annual European Congress 3-7 November 2012, Berlin, Germany, Nov 2012, Berlin, Allemagne. 15 (7), page A416, 2012. 〈halshs-00752908〉
  • Lionel Perrier, Alessandra Buja, Giuseppe Mastrangelo, Patrick Sylvestre-Baron, Petrus Pauwels, et al.. Cluster analysis and principal component analysis to access the variability of data in cost evaluations: methods and applications in oncology. ISPOR, 15th Annual European Congress 3-7 November 2012, Berlin, Germany, Nov 2012, Berlin, Allemagne. 15 (7), page A486, 2012. 〈halshs-00752878〉
  • Lionel Perrier. Adherence to practice guidelines for the management of patients with sarcoma: A cost-effectiveness assessment in two European regions. Meeting CONTICANET, Lyon, 7-8 juillet 2011, Jul 2011, Lyon, France. 〈halshs-00672128〉
  • Lionel Perrier. Conformity with clinical practice guidelines for management of patients with sarcoma: a cost-effectiveness assessment in two European regions. 16th annual conference of the Italian Health Economics Association (AIES) Second university of Naples, Naples, Italy, September 29-30, 2011, Sep 2011, Naples, Italy. 〈halshs-00672132〉
  • Lionel Perrier. Apports de l'évaluation médico-économique pour la décision publique en santé. Table ronde "Thérapies innovantes: lesquelles et à quel prix", Université Claude Bernard, Lyon, 24 novembre 2011, Nov 2011, Lyon, France. 〈halshs-00673319〉
  • Lionel Perrier. Costi del tratamento. Symposium Sarcomi delle parti molli et GIST : epidemologia, clinica e "network", Instituto oncologico Veneto, Padova, Italie, 6 mai 2011, May 2011, Padoue, Italie. 〈halshs-00625404〉
  • Lionel Perrier, Anne Lefranc, Philippe Quittet, Hervé Ghesquières, Bertrand Favier, et al.. Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in adult patients with lymphoma and myeloma: cost-effectiveness evaluation alongside a randomized controlled trial. 8th World congress on Health Economics, International Health Economics Association, Toronto, Canada, 10-13 juillet 2011, Jul 2011, Toronto, Canada. 〈halshs-00628854〉
  • Lionel Perrier, Anne Lefranc, Philippe Quittet, Philippe Moreau, Carole Siani, et al.. Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma. 16th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Baltimore, Etats-Unis, 25 mai 2011, May 2011, Baltimore, United States. 〈halshs-00628829〉
  • Lionel Perrier. Cost-effectiveness analysis: methods and applications in oncology. Interdisciplinary Research And Methodological Perspective seminaire, Università degli Studi di Padova, Dipartimento di Medicina Ambientale e Sanità Pubblica, Dipartimento di Scienze Oncologiche e Chirurgiche, 17 février 2010, Feb 2010, Padova, Italy. 〈halshs-00588784〉
  • Lionel Perrier. Cost-effectiveness analysis of compliance with clinical guidelines for sarcoma management. Connective Tissue Cancers Network (CONTICANET) Meeting, Institut Bergonié, Bordeaux, 23-24 mars, 2009, Bordeaux, France. 〈halshs-00451406〉
  • Lionel Perrier. Les évaluations de coûts en santé sont-elles transférables ? Mesures et application à une innovation très coûteuse en cancérologie. 29èmes Journées des Economistes Français de la Santé, Lille, 6-7 décembre 2007, 2007, Lille, France. 〈halshs-00267165〉
  • Marie-Odile Carrère, Lionel Perrier, Pascal Pommier, Patrick Sylvestre-Baron. Assessing the generalisability of cost evaluation results using the euclidean metric and principal components analysis : Lesson from a high-cost innovation in oncology. 10ème congrès européen de l'International Society for Pharmacoeconomics and Outcomes Research, Dublin, 20-23 octobre 2007, 2007, Dublin, Ireland. 〈halshs-00266793〉
  • Lionel Perrier. The contribution of the simulation for innovative technologies: The case of the hadrontherapy. NIRS-MedAustron Joint Symposium On Carbon Ion Therapy In Cancer, Innsbruck, 25-26 février 2006, 2006, Innsbruck, Austria. 〈halshs-00267144〉
  • Lionel Perrier. Report of work package 6 “Health economics aspects”. 10TH Workshop on Heavy Charged Particles in Biology and Medecine (HCPBM) and 4th Meeting of the European Network For Light Ion Hadron Therapy (ENLIGHT), Biella, juin 2005, 2005, Biella, Italy. 〈halshs-00267137〉
  • Marie-Odile Carrère, Lionel Perrier, Pascal Pommier, J. Rochat, Luciano Zucca. A model to calculate treatment cost per protocol for light ion facility radiotherapy projects in Europe. 5th World congress of the International Health Economics Association, Barcelone, 10th-13th July, 2005, Jul 2005, Barcelona, Spain. 〈halshs-00266174〉

Chapitre d'ouvrage1 document

  • Lionel Perrier. Organisation et financement des soins : vers une inadéquation croissante ?. Coordonné par Patrick Castel et Marie-Odile Carrère. Soins en réseau. Pratiques, acteurs et régulation en cancérologie, Editions John Libbey Eurotext, pp. 111-123, 2007. 〈halshs-00267179〉

Autre publication3 documents

  • Lionel Perrier, Magali Morelle, Nathalie Havet, Anthony Montella, Bertrand Favier, et al.. The effect of health care expenditures on survival in locally advanced and metastatic Non Small Cell Lung Cancer. Working Paper GATE 2009-03. 2009. 〈halshs-00371825〉
  • Lionel Perrier, Nicola Cautela, Magali Morelle, Nathalie Havet, Françoise Ducimetière, et al.. Short-Term cost impact of compliance with clinical practice guidelines for initial sarcoma treatment. Working paper GATE 08-22. 2008. 〈halshs-00322614〉
  • Lionel Perrier, Pascal Pommier, Marie-Odile Carrère, Patrick Sylvestre-Baron. Les évaluations de coûts en santé sont-elles transférables ?. Working Paper du GATE 2008-05. 2008. 〈halshs-00260873〉

Pré-publication, Document de travail4 documents

  • Marius Huguet, Xavier Joutard, Isabelle Ray-Coquard, Lionel Perrier. What underlies the observed hospital volume- outcome relationship?. Working paper GATE 2018-09. 2018. 〈halshs-01801598〉
  • Marius Huguet, Lionel Perrier, Olivia Bally, Xavier Joutard, Nathalie Havet, et al.. Counterfactual approach with survival or time to event outcomes: An application to an exhaustive cohort of Epithelial Ovarian Carcinoma in the Rhône-Alps region of France. Working paper GATE 2016-22. 2016. 〈halshs-01333480〉
  • Nathalie Havet, Alexis Penot, Magali Morelle, Lionel Perrier, Béatrice Fervers. Inégalités d'exposition aux agents cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel en France. Working paper GATE 2014-37. 2014. 〈halshs-01098761〉
  • Maria-Laura Silva, Lionel Perrier, Jean Marie Cohen, Anne Mosnier, John Paget, et al.. Literature review of the decision-­‐making determinants related to the influenza vaccination policy. Working paper GATE 2013-17. 2013. 〈halshs-00808536〉

Rapport1 document

  • Nathalie Havet, Alexis Penot, Magali Morelle, Lionel Perrier, Béatrice Fervers. Inégalités de l'exposition aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel : les enseignements de l'enquête SUMER: Rapport final de recherche pour la DARES, Ministère de la santé et de la solidarité. [Rapport de recherche] Direction de l'animation de la recherche, des études et des statistiques (DARES). 2014. 〈halshs-01080585〉